FDA Inspection 1077258 — Mercy Hospital St Louis Blood Bank
The FDA completed an inspection of Mercy Hospital St Louis Blood Bank on Jan 18, 2019 in Creve Coeur, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 18, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Creve Coeur, MO (United States)